Swiss hospital launches 20-year hunt for superbug patterns
NCT ID NCT04098133
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at patients infected with carbapenemase-producing bacteria (CPB), a type of superbug resistant to many antibiotics. Researchers will track 100 patients over 20 years to see how often these infections occur, how quickly they are detected, and what factors increase risk. The goal is to improve infection control and treatment timing, not to test a new drug.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help hospitals better detect and control dangerous, drug-resistant bacteria, potentially reducing infection spread.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly cure or prevent infections, and results may not apply to other hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTIONS WITH CPB are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Division of Infectious Diseases and Hospital Epidemiology
RECRUITINGBasel, 4031, Switzerland